enkephalin, leucine has been researched along with cysteine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fritschi, T; Fröscher, W; Maier, V | 1 |
| Davis, TP; Haaseth, RC; Horan, PJ; Hruby, VJ; Lipkowski, A; Misicka, A; Porreca, F; Weber, SJ; Wild, KD; Yamamura, HI | 1 |
| Lecchi, P; Loh, YP; Pannell, LK; Snell, CR | 1 |
| Capeyrou, R; Dietrich, G; Emorine, LJ; Gaibelet, G | 1 |
| Gioannini, TL; Hiller, JM; Onoprishvili, I; Simon, EJ | 1 |
| Blarzino, C; Cini, C; Coccia, R; Foppoli, C; Rosei, MA; Schininá, ME | 1 |
| Chalmers, MJ; Ferro, M; Gaskell, SJ; Gielbert, J; Gora, L; Mohammed, S; Smith, DC | 1 |
| Milanov, P; Naydenova, E; Pajpanova, T; Pencheva, N; Vezenkov, L | 1 |
| Choi, YS; Pennington, CL; Wood, TD | 1 |
9 other study(ies) available for enkephalin, leucine and cysteine
| Article | Year |
|---|---|
Periodic hypersomnia: case report with biochemical and EEG findings.
Topics: Adult; Arousal; Cerebral Cortex; Circadian Rhythm; Cysteine; Depressive Disorder; Diagnosis, Differential; Disorders of Excessive Somnolence; Electroencephalography; Enkephalin, Leucine; Follow-Up Studies; Humans; Male; Neurologic Examination; Periodicity; Sleep Stages; Syndrome; Wakefulness | 1991 |
Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
Topics: Amino Acid Sequence; Analgesics; Animals; Brain Chemistry; Cysteine; Enkephalin, Leucine; Male; Mice; Molecular Sequence Data; Oligopeptides; Rats; Receptors, Opioid, delta; Serine | 1993 |
The structure of synenkephalin (pro-enkephalin 1-73) is dictated by three disulfide bridges.
Topics: Amino Acid Sequence; Animals; CHO Cells; Cricetinae; Cysteine; Disulfides; Enkephalins; Molecular Sequence Data; Molecular Structure; Peptide Fragments; Protein Conformation; Protein Precursors; Protein Structure, Secondary; Rats; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trypsin | 1997 |
Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents.
Topics: Alkylating Agents; Alkylation; Animals; Binding Sites; Cloning, Molecular; COS Cells; Cysteine; Diprenorphine; Disulfides; Dithiothreitol; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Ethylmaleimide; Humans; Ligands; Mutagenesis, Site-Directed; Narcotic Antagonists; Protein Binding; Receptors, Opioid, mu; Reducing Agents; Sulfhydryl Reagents; Transfection | 1997 |
Inactivation of the purified bovine mu opioid receptor by sulfhydryl reagents.
Topics: Animals; Benzomorphans; Cattle; Cell Membrane; Corpus Striatum; Cysteine; Dithionitrobenzoic Acid; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Ethylmaleimide; Kinetics; Ligands; Naloxone; Radioligand Assay; Receptors, Opioid, mu; Sulfhydryl Reagents; Tritium | 1999 |
Cysteinyldopaenkephalins: synthesis, characterization and binding to bovine brain opioid receptors.
Topics: Analgesics, Opioid; Animals; Brain; Cattle; Chromatography, High Pressure Liquid; Cysteine; Enkephalin, Leucine; Enkephalins; Isomerism; Kinetics; Mass Spectrometry; Molecular Structure; Monophenol Monooxygenase; Oxidation-Reduction; Receptors, Opioid | 2000 |
A novel tandem quadrupole mass spectrometer allowing gaseous collisional activation and surface induced dissociation.
Topics: Amino Acid Sequence; Angiotensinogen; Bradykinin; Cysteine; Dynorphins; Enkephalin, Leucine; Fibrinopeptide A; Mass Spectrometry; Molecular Sequence Data; Molecular Structure; Peptide Fragments; Reproducibility of Results; Sensitivity and Specificity; Thermodynamics | 2001 |
Opioid profiles of Cys2-containing enkephalin analogues.
Topics: Animals; Cysteine; Dose-Response Relationship, Drug; Enkephalins; Guinea Pigs; Ileum; In Vitro Techniques; Kinetics; Male; Mice; Muscle Contraction; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Vas Deferens | 2004 |
Stable isotope labeling method targeting terminal tyrosine for relative peptide quantitation using mass spectrometry.
Topics: Amino Acid Sequence; Chromatography, Liquid; Cysteine; Enkephalin, Leucine; Isotope Labeling; Mass Spectrometry; Molecular Sequence Data; Monophenol Monooxygenase; Neuropeptides; Tyrosine | 2010 |